# A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects

> **NCT02208284** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06427878
- **DRUG:** Placebo
- **DRUG:** PF-06427878
- **DRUG:** Placebo
- **DRUG:** PF-06427878
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02208284
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02208284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02208284, "A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02208284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*